AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 195 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $44,907,813 | +129.1% | 557,861 | +127.1% | 0.01% | +125.0% |
Q1 2024 | $19,603,109 | +433.5% | 245,653 | +432.1% | 0.00% | +300.0% |
Q4 2023 | $3,674,114 | -15.8% | 46,163 | -26.1% | 0.00% | 0.0% |
Q3 2023 | $4,364,001 | -64.6% | 62,441 | -63.6% | 0.00% | -66.7% |
Q2 2023 | $12,329,163 | +230.2% | 171,572 | +183.5% | 0.00% | +200.0% |
Q1 2023 | $3,733,305 | -65.3% | 60,527 | -56.6% | 0.00% | -66.7% |
Q4 2022 | $10,756,472 | +40.9% | 139,459 | -18.5% | 0.00% | +50.0% |
Q3 2022 | $7,632,000 | +1527.3% | 171,050 | +1298.7% | 0.00% | – |
Q2 2022 | $469,000 | -9.1% | 12,229 | -1.9% | 0.00% | – |
Q1 2022 | $516,000 | +10.0% | 12,469 | +0.5% | 0.00% | – |
Q4 2021 | $469,000 | +4.7% | 12,413 | -8.8% | 0.00% | – |
Q3 2021 | $448,000 | -96.0% | 13,605 | -91.7% | 0.00% | -100.0% |
Q2 2021 | $11,089,000 | +48.2% | 164,383 | +24.4% | 0.00% | +50.0% |
Q1 2021 | $7,481,000 | -77.0% | 132,133 | -66.9% | 0.00% | -77.8% |
Q4 2020 | $32,514,000 | +6.8% | 399,092 | -6.6% | 0.01% | -10.0% |
Q3 2020 | $30,458,000 | -25.8% | 427,488 | -14.3% | 0.01% | -33.3% |
Q2 2020 | $41,028,000 | +6.0% | 498,639 | -24.2% | 0.02% | -6.2% |
Q1 2020 | $38,723,000 | -38.7% | 658,222 | +7.7% | 0.02% | -20.0% |
Q4 2019 | $63,190,000 | +228.9% | 611,359 | -35.6% | 0.02% | +300.0% |
Q3 2019 | $19,214,000 | -7.6% | 949,305 | +17.6% | 0.01% | 0.0% |
Q2 2019 | $20,793,000 | +39.1% | 807,509 | -23.1% | 0.01% | 0.0% |
Q1 2019 | $14,948,000 | – | 1,050,478 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |